MedPage Today on MSN
FDA Approves Sickle Cell Gene Therapy for Young Kids
Casgevy also now indicated for transfusion-dependent beta thalassemia in children 2 years ...
Gene editing has delivered remarkable results against sickle cell disease. Now researchers are working to make these ...
The company seems to be doing everything it's supposed to be doing; the stock just isn't responding.
The inventor of the groundbreaking Crispr gene-editing technology is skeptical about artificial intelligence replacing human ...
The gene editing tool known as CRISPR-Cas9 is changing what's possible for treating a wide range of diseases caused by genetic mutations. But so far, attempts to use the technology to address ...
Researchers discovered the secret checkpoints that keep CRISPR precise, revealing how the tool shifts from inactive to active without misfiring. The insight could transform gene therapy, making ...
A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...
A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...
A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results